PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2116517
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2116517
According to Mordor Intelligence, the disability devices market size is expected to grow from USD 22.43 billion in 2025 to USD 23.69 billion in 2026 and is forecast to reach USD 31.14 billion by 2031 at a 5.62% CAGR over 2026-2031.

This report is Segmented by Device Type (Vision Aids, and More), End User (Home Care Settings, and More), Distribution Channel (Retail Pharmacies & DME Stores, E-Commerce Platforms, and Direct-To-Customer), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).
Population aging is the strongest structural driver for the disability devices market. The World Health Organization projects that the global 60-plus cohort will reach 2.1 billion by 2050, with approximately 70% of adults over 70 experiencing clinically significant hearing loss. Japan's super-aged profile (29% of citizens already over 65) illustrates rising device intensity; roughly 1.2 million hearing aids were dispensed nationwide in 2025, nearly double the per-capita rate observed in the United States. Multiple comorbidities among older adults (stroke, osteoarthritis, diabetic neuropathy) are accelerating demand for multimodal platforms that combine fall detection, medication reminders, and emergency communication. Vendors capable of bundling such capabilities within a single interface are therefore best positioned to capture wallet share. Over the long term, demographic momentum ensures a stable baseline growth rate of at least 1.2 percentage points, contributing to the overall CAGR.
Coverage expansion is widening access to premium devices. In the United States, Medicare processed more than USD 8 billion in Durable Medical Equipment, Prosthetics, Orthotics, and Supplies claims in 2025, and its 2024 rule change allowing over-the-counter hearing aids priced below USD 1,500 cut beneficiary out-of-pocket spending by roughly 40%. Germany's statutory insurers reimburse up to EUR 1,500 (USD 1,650) every six years for hearing aids, while France covers 60% of prosthetic costs up to EUR 2,500 (USD 2,750). Such reimbursement ceilings establish price bands and compel manufacturers to develop tiered product portfolios that align with payer thresholds. ISO 13485 certification increasingly serves as a gatekeeper for market entry, nudging small innovators toward strategic partnerships with established contract manufacturers.
Premium aids remain expensive relative to household income in many regions. Microprocessor-controlled transfemoral limbs cost USD 50,000 to USD 100,000, while cochlear implant systems cost USD 30,000 to USD 50,000 before surgical fees. The World Health Organization estimates that 90% of people needing assistive technology lack access, primarily due to the high cost. Even in high-income markets, Medicare coinsurance requires beneficiaries to cover 20% of DMEPOS costs, translating to a range of USD 3,000-6,000 for a power wheelchair. This expense is driving a secondary market for refurbished devices, but liability concerns and lack of standard quality protocols continue to constrain supply.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Communication Aids are expected to register a 7.54% CAGR from 2026 to 2031, reflecting the mainstreaming of augmentative and alternative communication platforms within classrooms and offices. The disability devices market size for Communication Aids is forecast to surpass USD 6 billion by 2031, as speech-generating devices integrate eye-tracking, natural language processing, and cloud-based vocabulary updates. Tobii Dynavox reported a 22% year-over-year increase in shipments in 2024, following its partnership with North American school districts. Mobility Aids, despite holding 34.34% of the disability devices market share in 2025, are transitioning from manual wheelchairs to sensor-rich power models that self-navigate narrow corridors and curb cuts. Permobil's M5 Corpus, launched late 2024, exemplifies the shift with LiDAR-based collision avoidance and GPS routing.
Demand for Hearing Aids remains buoyant as over-the-counter devices, priced at USD 200-1,500 per pair, widen access. Sonova's Sphere Infinio, the first hearing aid with an on-board AI speech-enhancement chip, delivers a 10-decibel improvement in background noise environments and extends battery life to 36 hours. Vision Aids are evolving from legacy magnifiers to AI-enabled wearables such as OrCam MyEye that translate text and identify faces. Daily living aids, dominated by adaptive utensils and bright pill dispensers, retain fragmentation but gain traction in aging-in-place scenarios, where Bluetooth medication reminders help lower hospital readmissions.
North America contributed 43.54% of disability devices market revenue in 2025, underpinned by Medicare's USD 8 billion annual DMEPOS spend and the Department of Veterans Affairs' prosthetic benefits for 9 million veterans. High per-capita health expenditure, robust billing codes, and the FDA's expedited Technology Certification pathway speed time to market for breakthrough aids. Growth is moderating, however, as urban penetration plateaus and reimbursement models shift toward value-based contracting, which rewards functional outcomes instead of device volume.
The Asia-Pacific region is expected to record the fastest growth, with a 6.43% CAGR through 2031, as China, Japan, and India confront rapid demographic aging. China's population aged 60 and above reached 280 million in 2025 and is expected to surpass 400 million by 2035, prompting increased municipal procurement of ramps and tactile paving under the Barrier-Free Environment Construction Law. Japan subsidizes up to 90% of device costs for low-income seniors, making it the world's highest per-capita consumer of hearing aids. India reimburses up to 50% of aid costs for households below the poverty line, though caps limit access to advanced imports. Smart-device penetration is lower than in the West, but volume growth from cost-engineered manual aids offsets the mix.
Europe accounted for 28% of 2025 revenue. Reimbursement differs by nation; Germany offers EUR 1,500 per hearing aid every six years, while France covers 60% of prosthetic costs up to EUR 2,500. The Medical Device Regulation raises compliance costs yet improves traceability and post-market vigilance. The Middle East, Africa, and South America collectively accounted for approximately 10% of sales, largely due to low insurance penetration and fragmented supply chains. Brazil's Inclusion Law mandates workplace accommodations, but enforcement outside major cities remains patchy.